| Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials JJ Leow, W Martin-Doyle, PS Rajagopal, CG Patel, EM Anderson, ... European urology 66 (1), 42-54, 2014 | 461 | 2014 |
| Distinct pattern of metastases in patients with invasive lobular carcinoma of the breast A Mathew, PS Rajagopal, V Villgran, GS Sandhu, RC Jankowitz, M Jacob, ... Geburtshilfe und Frauenheilkunde 77 (06), 660-666, 2017 | 101 | 2017 |
| PhenomeXcan: Mapping the genome to the phenome through the transcriptome M Pividori, PS Rajagopal, AN Barbeira, Y Liang, O Melia, L Bastarache, ... Science Advances 6 (37), eaba2083, 2020 | 94 | 2020 |
| Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics … P Horak, M Griffith, AM Danos, BA Pitel, S Madhavan, X Liu, C Chow, ... Genetics in Medicine 24 (5), 986-998, 2022 | 78 | 2022 |
| Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations S Feurstein, A Adegunsoye, D Mojsilovic, R Vij, AH West DePersia, ... Blood advances 4 (19), 4873-4886, 2020 | 31 | 2020 |
| Employment trends in young women following a breast cancer diagnosis SM Rosenberg, I Vaz-Luis, J Gong, PS Rajagopal, KJ Ruddy, RM Tamimi, ... Breast cancer research and treatment 177, 207-214, 2019 | 28 | 2019 |
| Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes N Ansari-Pour, Y Zheng, TF Yoshimatsu, A Sanni, M Ajani, JB Reynier, ... Nature Communications 12 (1), 1-15, 2021 | 24 | 2021 |
| Chemotherapy for advanced cancers PS Rajagopal, RD Nipp, KJ Selvaggi Ann Palliat Med 3 (3), 203-228, 2014 | 19 | 2014 |
| The time for mainstreaming germline testing for patients with breast cancer is now PS Rajagopal, DVT Catenacci, OI Olopade Journal of Clinical Oncology 37 (24), 2177, 2019 | 13 | 2019 |
| USPSTF recommendations for BRCA1 and BRCA2 testing in the context of a transformative national cancer control plan PS Rajagopal, S Nielsen, OI Olopade JAMA network open 2 (8), e1910142-e1910142, 2019 | 13 | 2019 |
| Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome G Dinstag, ED Shulman, E Elis, DS Ben-Zvi, O Tirosh, E Maimon, ... Med, 2022 | 12 | 2022 |
| Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer SP Kar, DPC Considine, JP Tyrer, JT Plummer, S Chen, FS Dezem, ... Human Genetics and Genomics Advances 2 (3), 2021 | 12 | 2021 |
| A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab DJ Olson, P Rajagopal, MY Tjota, G Venkataraman, JJ Luke, TF Gajewski Journal for immunotherapy of cancer 8 (1), 2020 | 9 | 2020 |
| Cross-species identification of cancer resistance–associated genes that may mediate human cancer risk NU Nair, K Cheng, L Naddaf, E Sharon, LR Pal, PS Rajagopal, ... Science Advances 8 (31), eabj7176, 2022 | 8* | 2022 |
| Black Lives Matter Worldwide: Retooling Precision Oncology for True Equity of Cancer Care PS Rajagopal, OI Olopade Cell Reports Medicine 1 (5), 100079, 2020 | 8 | 2020 |
| Development and Pilot Testing of a Simulation to Study How Physicians Facilitate Surrogate Decision Making Based on Critically Ill Patients' Values and Preferences LP Scheunemann, R Khalil, PS Rajagopal, RM Arnold Journal of pain and symptom management 57 (2), 216-223. e8, 2019 | 4 | 2019 |
| Characterization of Oncology Clinical Trials Using Germline Genetic Data AV Kammula, AA Schäffer, PS Rajagopal JAMA Network Open 5 (11), e2242370-e2242370, 2022 | 3 | 2022 |
| Abstract P4-05-10: Comparative analysis of genomic landscape reveals heterogeneity in HER2-positive primary breast cancers and residual disease following neoadjuvant therapy M Hattori, D Huo, N Beaubier, PS Rajagopal, T Yoshimatsu, Y Zheng, ... Cancer Research 80 (4_Supplement), P4-05-10-P4-05-10, 2020 | 2* | 2020 |
| Outcome differences by sex in oncology clinical trials AV Kammula, AA Schäffer, PS Rajagopal, R Kurzrock, E Ruppin Nature Communications 15 (1), 2608, 2024 | 1 | 2024 |
| Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues N Sanghvi, C Calvo-Alcañiz, P Rajagopal, S Scalera, V Canu, S Sinha, ... bioRxiv, 2023.10. 30.564810, 2023 | 1 | 2023 |
